Advertisement
News
Subscribe to MDT Magazine News

Penn Study Shows New Measure Trumps HDL Levels in Protecting Against Heart Disease

January 12, 2011 5:33 pm | by University Of Pennsylvania | Comments

Recent findings have called into question the notion that pharmacologic increases in high-density lipoprotein (HDL) cholesterol (the "good cholesterol") are necessarily beneficial to patients. Now, a new study from researchers at the University of Pennsylvania School of Medicine and...

TOPICS:

AACR Recognizes the Outstanding Achievements of Pier Paolo Pandolfi

January 12, 2011 5:32 pm | by AACR | Comments

PHILADELPHIA - Pier Paolo Pandolfi, M.D., Ph.D., is the recipient of the 2011 Pezcoller Foundation-AACR International Award for Cancer Research for his outstanding work in the field of cancer genetics and mouse models for cancer. This work has contributed to new therapies for treating cancers.

TOPICS:

Fitch Ratings revises insurer outlooks to 'stable'

January 12, 2011 10:45 am | by The Associated Press | Comments

Fitch Ratings said Wednesday it now expects the impact of the federal government's overhaul of health insurance on insurers' operating fundamentals to be manageable.The ratings agency upgraded its rating outlook for the health and managed-care sectors to "stable" from "negative" but said the...

Advertisement

TSX-listed corporate dividends and distributions declared Jan. 12, 2010

January 12, 2011 9:45 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on January 12, 2011.Power Financial Corp. Ser A Fltg Rate (TSX:PWF.PR.A): $0.13125. Payable Feb 15. Record Jan 25.Bombardier Inc. Cl 'a' Mv (TSX:BBD.A): $0.025. Payable Jan 31. Record...

Neogen gets approval for Salmonella test

January 12, 2011 8:45 am | by Associated PressAssociated Press | Comments

Neogen Corp., which makes test kits for food and animal safety, said Wednesday the Food and Drug Administration approved its test for Salmonella.The company said its test is equivalent to current methods in accuracy, precision, and sensitivity but shortens the testing time. The newly approved test...

Medical software firm iMedX lands $2.5M

January 12, 2011 7:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Shelton, Conn.-based iMedX Inc., a provider of medical transcription software and services, has raised a $2.5 million equity financing, according to a regulatory filing.

NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011

January 12, 2011 7:37 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 12, 2011 /- NeoStem, Inc. (NYSE Amex: NBS ) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that Dr. Robin Smith, the Company's Chairman and CEO, will present on Wednesday, January 12, 2011 at...

TOPICS:

K-V Pharmaceutical Company Updates Status of New Drug Application for Gestivaâ„¢

January 12, 2011 7:35 am | by Bio-Medicine.Org | Comments

ST. LOUIS, Jan. 12, 2011 /- K-V Pharmaceutical Company (NYSE:  KVa/KVb) today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s (Hologic) New Drug Application (NDA) for Gestiva™ (hydroxyprogesterone caproate injection) as a...

TOPICS:
Advertisement

InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA

January 12, 2011 7:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 12, 2011 /- InstaCare Corp. (OTC Bulletin Board:  ISCR) a leading provider of prescription and non-prescription diagnostics, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of...

TOPICS:

St. Jude Medical 4Q revenue exceeds estimates

January 12, 2011 6:45 am | by The Associated Press | Comments

St. Jude Medical Inc. said Friday that its revenue grew 12 percent in the fourth quarter, surpassing Wall Street's expectations as sales of its heart devices improved.The company said it expects to report about $1.35 billion in revenue for the quarter. St. Jude has forecast a profit of 72 cents...

Amica Mature Lifestyles Q2 revenue rises, company reports a profit

January 12, 2011 4:45 am | by The Associated Press | Comments

Amica Mature Lifestyles Inc. (TSX:ACC) says it had a $200,000 profit in its fiscal second quarter, an improvement on the $353,000 loss it inclurred in the year-earlier period. The Vancouver-based company, which manages and owns luxury retirement communities, also saw revenue improve to $13.7...

Ocular Therapeutix pushes last round to $21M

January 12, 2011 3:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Ocular Therapeutix Inc., another eye therapy company launched by Amar Sawhney, has boosted its most recent funding round to $21 million, just days after Sawhney's Eyegate Pharmaceuticals Inc. itself announced a funding bump.

New drug uses stealth to stop cancer cell reproduction

January 12, 2011 3:35 am | by EurekAlert | Comments

(Scottsdale Healthcare) A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. The Virginia G. Piper Cancer Center at Scottsdale Healthcare is one of three US sites participating in a Phase I clinical trial...

TOPICS:

Caliper and Seegene Partner to Provide Innovative Multiplex Molecular Diagnostics Products

January 12, 2011 3:34 am | by Bio-Medicine.Org | Comments

HOPKINTON, Mass. and SEOUL, Korea, Jan. 12, 2011 /- Caliper Life Sciences, Inc. (Nasdaq: CALP ) and Seegene, Inc. (KOSDAQ: A096530) today announced that they have entered into a strategic partnership to enable Seegene's SeePlex™ multiplex diagnostic assays to run on Caliper's...

TOPICS:

Millennium Laboratories to Provide UnitedHealthcare's Nationwide Network of Physicians Drug Monitoring and Pain Management Services

January 12, 2011 2:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Jan. 12, 2011 /- Millennium Laboratories , a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced it will provide pain management and therapeutic drug monitoring services to physicians participating in...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading